Head-to-head · WeighScore
ShapeIn Rx vs Spry
The verdict
ShapeIn Rx takes it — 60.4/100 to 56.8/100.
ShapeIn Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Phoenix-based telehealth from WellHealth LLC selling compounded semaglutide with B12 and daily compounded liraglutide, with telemedicine limited to states where its providers are licensed.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | ShapeIn Rx | Spry |
|---|---|---|
| WeighScore | 60.4/100 | 56.8/100 |
| Grade | C | C |
| Scorecard rank | #325 | #409 |
| Semaglutide | $199/mo (compounded) | $199/mo (starting dose, compounded) |
| Tirzepatide | Not disclosed | $299/mo (starting dose, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #325 · C
Strengths
- One of the few telehealth providers offering compounded liraglutide as a daily alternative to weekly injections
- Semaglutide is compounded with B12, and the combination is stated plainly
- Publishes a street address and a staffed phone line with hours
- States openly that telemedicine is limited to jurisdictions where its providers are licensed, rather than claiming all 50
- LegitScript certification verified against the issued seal, not just the badge
Where it loses points
- Advertises Trusted by 150k Americans and Excellent 4.8 with 150k happy customers, and neither figure is attributable to a verifiable review profile
- No state list is published, only a statement that coverage is limited and a note that partner pharmacies may operate in all 50 states
- The struck-through $199 next to $149 on the homepage reads as a discount but the two prices are different medications
- Claims No Hidden Fees and No Monthly Membership while the Terms state subscriptions automatically renew
- No compounding pharmacy is named, only US-Certified Pharmacy
Graded #409 · C
Strengths
- Three named co-founders disclosed (Gabriel Mullins, Sara Yoder, Tyler Bowman) — better-than-average transparency
- Pricing shown on the homepage ($199 semaglutide / $299 tirzepatide / $249–$299 peptides) — no full sign-up wall
- Broader range (2 GLP-1s plus 3 anti-aging peptides) appeals to longevity buyers
- No contracts or commitment required
- LegitScript Certified with a public verification link
Where it loses points
- Displays an "FDA Approved" badge though compounded GLP-1s are not FDA-approved finished drugs — potentially misleading
- Intake reviewed by a nurse practitioner, not an MD
- States served not disclosed publicly
- Pharmacy partner not named, and 503A vs 503B designation not specified
- FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.